---
title: "After bariatric surgery: tirzepatide nutrition-lab, glucose and symptom record (printable) | HealthRX.com"
description: "Record your procedure and weight history, the nutrition labs before starting and at each check, and any low-glucose episodes, with what the evidence and the label say and the symptoms that need a same-day call."
url: https://healthrx.com/printables/zepbound-v2/post-bariatric-considerations
publisher: HealthRX.com
---


[Back to the article](https://healthrx.com/zepbound-v2/post-bariatric-considerations)

HealthRX.com · Printable lab tracker

# After bariatric surgery: tirzepatide nutrition-lab, glucose and symptom record

Record your procedure and weight history, the nutrition labs before starting and at each check, and any low-glucose episodes, with what the evidence and the label say and the symptoms that need a same-day call.

Companion to “Zepbound After Bariatric Surgery: What Patients and Clinicians Need to Know” · healthrx.com/zepbound-v2/post-bariatric-considerations · Facts checked Oct 18, 2026

## Surgery and weight history

Procedure and date sleeve, Roux-en-Y bypass, one-anastomosis bypass, band or revision

Weight before surgery

Lowest weight after surgery, and when

Weight now

Supplements you take now

## Nutrition labs

Record results with the lab's reference range; your team decides which tests and when.

| Test | Before starting | Month 3 | Month 6 | Month 12 |
| --- | --- | --- | --- | --- |
| Ferritin |  |  |  |  |
| Vitamin B12 |  |  |  |  |
| 25-OH vitamin D |  |  |  |  |
| Thiamine |  |  |  |  |
| Zinc |  |  |  |  |
| HbA1c |  |  |  |  |

## Low-glucose episodes

| Date and time | Time since eating | Reading, if checked | Symptoms | What you did |
| --- | --- | --- | --- | --- |

## What the evidence and the label say

- Pooled from 8 retrospective studies after bariatric surgery: 13.63% weight loss with tirzepatide (95% CI 4.67% to 22.59%) and 10.97% with semaglutide. [1]
- In one single-centre observational cohort of 34 patients, with no comparison group, mean weight loss at 24 weeks was 18.1%. [2]
- With insulin or a sulfonylurea, the label says lowering those doses may reduce the risk of low blood sugar. [3]
- Low blood sugar signs listed in the label include dizziness, sweating, confusion, shakiness and a fast heartbeat. [3]

## Call the same day

- Vomiting or diarrhea that stops you keeping fluids down: fluid loss can cause kidney problems. [3]
- Upper stomach pain with fever, yellow skin or eyes, or clay-colored stools: possible gallbladder problem. [3]

## Questions for the bariatric team

1. Is my weight regain anatomical, such as a stretched pouch, or something medicine can address?
2. How slowly should my dose go up after my procedure?
3. Do I need a glucose monitor before I start?
4. Which supplements should change while I am eating less?

**Sources for the facts on this sheet**

1. Osorio Manyari AA, Armas Alvarez AL, Osorio Manyari JD, et al. Effects of Semaglutide and Tirzepatide on Recurrent Weight Gain After Bariatric Surgery: A Systematic Review and Meta-analysis. Obes Surg 2025. PMID 41313431. [https://pubmed.ncbi.nlm.nih.gov/41313431/](https://pubmed.ncbi.nlm.nih.gov/41313431/)
2. Vinciguerra F, Di Stefano C, Guccione F, et al. Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety. Obes Surg 2026. PMID 42247124. [https://pubmed.ncbi.nlm.nih.gov/42247124/](https://pubmed.ncbi.nlm.nih.gov/42247124/)
3. Eli Lilly and Company, via DailyMed. Zepbound (tirzepatide) injection, for subcutaneous use: prescribing information and Medication Guide. Effective 2026-08-28. [https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)

This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.
